Details for New Drug Application (NDA): 210497
✉ Email this page to a colleague
The generic ingredient in BUPROPION HYDROCHLORIDE is bupropion hydrochloride. There are thirty-eight drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride profile page.
Summary for 210497
Tradename: | BUPROPION HYDROCHLORIDE |
Applicant: | Accord Hlthcare |
Ingredient: | bupropion hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 210497
Mechanism of Action | Dopamine Uptake Inhibitors Norepinephrine Uptake Inhibitors |
Physiological Effect | Increased Dopamine Activity Increased Norepinephrine Activity |
Suppliers and Packaging for NDA: 210497
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 210497 | ANDA | Accord Healthcare Inc. | 16729-443 | 16729-443-10 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-10) |
BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 210497 | ANDA | Accord Healthcare Inc. | 16729-443 | 16729-443-15 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-15) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 150MG | ||||
Approval Date: | Oct 31, 2018 | TE: | AB3 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Oct 31, 2018 | TE: | AB3 | RLD: | No |
Complete Access Available with Subscription